Moody's Investors Service has assigned an "A2" rating to Orlando (Fla.) Health, affecting $337 million of proposed revenue bonds.
The rating reflects Moody's expectation that the system's balance sheet and operating leverage will remain high in the short term with sizable capital plans that will accommodate growth strategies in a competitive market. The rating also reflects Orlando Health's consistently favorable financial results and liquidity gains.
The rating outlook has been revised from positive to stable.